Add like
Add dislike
Add to saved papers

Unregulated pollutant emissions from on-road vehicles in China, 1999-2014.

Multi-year (1999-2014) vehicular unregulated pollutants emissions in China, including SO2 , CH4 , N2 O, NH3 , Indeno(1,2,3-cd)pyrene (IPY), Benzo(k)fluoranthene (BkF), Benzo(b)fluoranthene (BbF), Benzo(a)pyrene (BaP), dioxins and furans, were estimated based on emission factors calculated by COPERT. The inter-annual trends, correlation with GDP and population, spatial distribution characteristics, contributions from various vehicle types for the ten pollutants emissions were analyzed. Results showed that the emissions of the above ten pollutants changed from approximately 576.9Gg, 130.0Gg, 8.1Gg, 2.1Gg, 1.0Mg, 1.1Mg, 1.4Mg, 0.5Mg, 7.4g and 15.6g in 1999 to 193.8Gg, 171.1Gg, 79.1Gg, 117.8Gg, 3.5Mg, 6.7Mg, 6.8Mg, 2.9Mg, 37.6g and 79.1g in 2014, respectively. Implementation of stringent sulfur content limit during the past decade reduced approximately 94.4% of the SO2 emission in 2014. CH4 and N2 O increased from 1999 to 2011, but began to decrease since 2012; NH3 emission had the highest annual average change rate (35.5%) from 1999 to 2014; PAHs, dioxins and furans increased continuously during the past decade. The vehicular emissions were higher in Guangdong, Shandong, Henan, Jiangsu, Zhejiang and Hebei. Good linear correlation between vehicular emissions and GDP was found (except SO2 ); in the provinces/municipalities with higher population density, the emission density was also larger, indicating more significant vehicular emissions' potential damage on human health. HDT and PC, PC and MC, PC and BUS were the major contributors to SO2 , CH4 , N2 O emissions, respectively. In 2014, PC was the dominant contributor to NH3 emission; PC, BUS and HDT had higher fraction in the total IPY and BaP emissions; HDT was the major contributor to BkF and BbF emissions. In addition, the uncertainties of estimated emissions were also analyzed based on Monte Carlo simulation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app